Spravato (Esketamine) Nasal Spray
What is TRD (Treatment-Resistant Depression?)
Spravato is the only FDA approved nasal spray for treating adults with TRD (Treatment-resistant depression) or MDD (Major Depressive Disorder). It helps to reduce symptoms of depression for patients who have previously attempted two or more oral antidepressants and have found them to be unsuccessful.
MD TruCare is a Certified SPRAVATO Treatment Center
Several studies show that 1/3 of the patients with depression don’t get better just with antidepressant medications, and adding Spravato treatment dramatically improves their chances of getting better.
Why MD TruCare for Spravato?
Expertise:
- Board-certified Psychiatrist on site
- Knowledgeable, experienced, and dedicated staff
Scheduling:
- Comprehensive Initial Evaluations
- Easy and efficient scheduling
- Timely Insurance Approvals
Care:
- Clean and Inviting Atmosphere
- Wifi provided during sessions
- Blankets and Candy available upon request
The Effectiveness of Spravato:
Spravato has been proven to aid in depressive symptoms and has demonstrated a rapid improvement.
Treatment is standardized and highly supervised. 50-70% of patients exhibit a significant response to treatment, leading to a decrease in depressive symptoms.
With an innovation way of care, such as Spravato, patients can find another solution.
What to Know about Spravato:
- - Complete a Psychiatric Evaluation to determine whether Spravato is right for you
- - Notify your provider of any pre-existing conditions or health concerns
- - Check in and get vitals taken
- - Get set up in Spravato room
- - Sessions last approx.2 hrs.
- - Ensure you are comfortable during your treatment, if you are experiencing any unease, alert the provider
- - Bring entertainment! (Book, tablet, music, etc.)
- - Have a ride arranged to pick you up from your appointment (after treatment, you are not able to operate machinery for some time)
- - Continue to monitor symptoms (Relief may begin after session or as early as 1-2 weeks)
*Remember: Stay patient! Results may take time. Track any changes and communicate with your provider*
Frequently Asked Questions
FAQ
How long does each session take?
Each session is approximately 2 hours.
Is Spravato (esketamine) covered by insurance?
It is eligible for coverage by most commercial insurances.
How is Spravato (esketamine) different from other treatments?
It works as a fast-acting treatment for depression and is used when traditional antidepressants haven’t been effective.
Is Spravato FDA Approved?
Yes! Spravato (esketamine) is the only FDA-approved nasal spray for Treated Resistant Depression.
We are accepting patients for Spravato! Click here to see how you can begin treatment
Testimonials
SPRAVATO Monitoring
SPRAVATO Room
Why choose MD TruCare from Spravato treatment
- Board-certified Psychiatrist on site
- Knowledgeable, experienced, and dedicated Spravato team
- Easy scheduling
- Comprehensive Initial Evaluations
- Close monitoring and supervision during treatments
- A clean and inviting atmosphere
- Timely insurance approvals
“We’ve always prided ourselves in offering the most advanced treatments to our patients"
“Insurance coverage of SPRAVATO/esketamine now allows this life-saving treatment to be accessible to patients that need it”
"With one-third of those suffering from depression unable to respond to antidepressant medications, being able to provide relief to patients that are otherwise treatment resistant is promising.”
Imran S Khawaja, MD, FAASM, MD TruCare
Why choose MD TruCare from Spravato treatment
- Board-certified Psychiatrist on site
- Knowledgeable, experienced, and dedicated Spravato team
- Easy scheduling
- Comprehensive Initial Evaluations
- Close monitoring and supervision during treatments
- A clean and inviting atmosphere
- Timely insurance approvals
As teaching faculty and researchers, we pride ourselves on offering our patients the most advanced and evidence-based treatments.
Insurance coverage of SPRAVATO (Esketamine) now allows this life-saving treatment to be accessible to our patients who need it.
Several studies show that 1/3 of the patients with depression don't get better just with antidepressant medications, and adding Spravato treatment dramatically improves their chances of getting better.
Imran S Khawaja, MD, FAASM
CEO, MD TruCare
Clinical Professor, Department of Psychiatry, University of Oklahoma
MD TruCare is a Certified SPRAVATO Treatment Center
SPRAVATO™ nasal spray is a different kind of medication taken with an oral antidepressant for adults with treatment-resistant depression – a first in decades approved by the FDA.
If you’ve struggled with depression and tried two or more antidepressants* in your current episode without adequate relief, talk to your provider at MD TruCare to see if you have treatment-resistant depression. This treatment is covered by most insurance.
This treatment is for those with depression who have failed at least two antidepressants. Patients will be required to have someone drive them home and will need to stay in our office for two hours. The initial treatment consists of twice weekly treatments for four weeks and then treatment once weekly. Ongoing treatment is usually required.
Learn more about SPRAVATO at https://www.spravato.com/